ProShares Ultra Health Care (RXL)

  • Loading...

Fund Description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.

Fund Snapshot Updated 04.17.2014

Previous Close $84.68 Expense Ratio 0.95%
YTD Return 4.33% Avg. 30-Day Volume 22,408
1-Year Return 46.4% Market Cap Loading...
Bid $84.45 Shares Outstanding 1,125,000
Ask $84.81 Dividends $0.21
Top 10 Holdings
Johnson & Johnson (JNJ) 12.11%
Pfizer Inc (PFE) 8.35%
Merck & Co Inc New (MRK) 7.19%
Gilead Sciences Inc (GILD) 4.66%
Amgen Inc (AMGN) 3.77%
Bristol Myers Squibb Co (BMY) 3.52%
Abbvie Inc (ABBV) 3.34%
Unitedhealth Group Inc (UNH) 3.24%
Biogen Idec Inc (BIIB) 2.97%
Abbott Labs (ABT) 2.60%
% of Total Holdings 51.80%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds